 |
With expertise in clinical pharmacology, regulatory affairs,
pharmacokinetics, pharmacometrics, biopharmaceutics, and
bioanalytical, ICON Development Solutions specializes in the
strategy, management and execution of product development
and early phase clinical development. |
| |
|
|
ICON Central Laboratories provides central laboratory testing
and associated services dedicated exclusively to clinical trials.
We have conducted over 1,500 studies and support 34,000
investigator sites worldwide for trials in Phase I – IV in all
therapeutic areas. |
| |
|
|
ICON Development Solutions has conducted over 1000 clinical
studies, from Phase I Healthy Volunteer studies to Phase IIA
Patient studies. We have applied our expertise in pharmaco-
dynamic (PD) models across a range of therapeutic targets and
have conducted over 40 PD-focused studies. |
| |
|
|
ICON Development Solutions has one of the most experienced
regulatory groups in the industry, with a proven track record of
success in regulatory submissions (IND, CTA, MAA, NDA, CTD)
and regulatory agency/authority interactions. |
| |
|
|
